Five Star Equities Provides Stock Research on Astex Pharmaceuticals and BioTime
Continue ReadingTag: five-star-equities
Despite Posting Mixed Fourth Quarter Earnings U.S. Airlines Showing Investors Strong Gains in 2013
Five Star Equities Provides Stock Research on Alaska Air Group and JetBlue Airways
Continue Reading
Biotech Industry Expected to Experience More M&A Activity in 2013
Five Star Equities Provides Stock Research on Array Biopharma and Venaxis
Continue Reading
Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With Cash
Five Star Equities Provides Stock Research on Cyclacel Pharmaceuticals and DARA Biosciences
Continue Reading
Despite Posting Mixed Fourth Quarter Earnings U.S. Airlines Showing Investors Strong Gains in 2013
Five Star Equities Provides Stock Research on Southwest Airlines and United Continental Holdings
Continue Reading
Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for Replacements
Five Star Equities Provides Stock Research on Questcor Pharmaceuticals and Sequenom
Continue Reading
Mergers and Acquisitions on the Rise in 2013 as Big Pharma Companies Hold Record Amounts of Cash on Hand
Five Star Equities Provides Stock Research on Cytori Therapeutics and Peregrine Pharmaceuticals
Continue Reading
Sharp Rise in Investment Demand Ignites Rally in Silver Prices
Five Star Equities Provides Stock Research on iShares Silver Trust ETF and Silver Standard Resources
Continue Reading
Strong Investment Demand to Drive Silver Industry in 2013
Five Star Equities Provides Stock Research on First Majestic Silver and Endeavour Silver
Continue Reading
Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013
Five Star Equities Provides Stock Research on Antares Pharma and Celldex Therapeutics
Continue Reading